Default company panoramic image
Ab461b75 3879 48b5 9ee5 90e7a6f1cc0e

Boston Therapeutics Inc.

The company just got the permission to submit PAZAMET as Abriviation New Drug Application with the FDA with no additional clinical trials.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location United States
  • Currency USD
  • Founded August 2009
  • Employees 7
  • Website bostonti.com

Company Summary

Boston Therapeutics Inc. develped an anti diabetic drug called PAZAMET and a food supplement called SUGARDOWN to prevent post meal elevation of blood glucose for pre diabetics and diabetics of 400,000,000 people world wide.

Team

Advisors

  • Default avatar
    Sayfart Shaw
    Lawyer
    Unconfirmed
    Default avatar
    Macladery
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    Self funded
    Unconfirmed
    Default avatar
    100 individual investors
    Unconfirmed
    Default avatar
    Advance Pharmaceuticals Inc.
    Unconfirmed